Skip to main content
. 2023 Feb 17;16(2):315. doi: 10.3390/ph16020315

Figure 8.

Figure 8

Imaging and treatment of prostate cancer in mouse models using PSMA-targeted liposome-like texaphyrin NPs. (A) Synthetic scheme showing chelation of lutetium with texaphyrin−lipid. (B) Formulation and representation of nanotexaphyrin self-assembly. (C) Radiolabeling conditions and schematic representation of 111In/Lu-labelled nanotexaphyrin. (D) Schematic representation of PSMA-targeting ligand (ACUPA) conjugated 111In/Lu–nanotexaphyrin. (E) mSPECT/CT images of a mouse model bearing dual xenografts of PC3-Pip and PC3-Flu. Reprinted with permission from Ref [61]. Copyright 2022, American Chemical Society.